Prof. Dr. Dr. Bernd Nürnberg
- 1977
University Entrance Qualification - 1977-1978
Compulsary Military Service, Medical Corps of the German Army Air Force (last rank: Corporal First Class) - 1978-1982
Studies of Pharmacy at the Julius-Maximilians-University of Wuerzburg - 1982-1988
PhD student and Postdoc at the Institute of Pharmacology and Toxicology, Friedrich-Alexander-University of Erlangen-Nuernberg (Chair: Kay Brune, M.D.) - 1983
Licensed Pharmacist - 1986
Ph.D. (Dr. rer. nat.), advisor: Prof. Dr. Kay Brune, theme: New aspects of the resorption and elimination of diflunisal – a modern salicyclate (Neue Aspekte der Resorption und Elimination von Diflunisal - einem modernen Salicylat) - 1983-1989
Studies of Human Medicine at the University of Erlangen-Nuernberg und University of Sydney, Australia - 1987
Consultant at the Division of Rheumatology (Head: Prof. Daniel Furst, M.D.), University of Iowa Hospitals and Clinics, Iowa City, and Research Fellow at the Department of Pharmacodynamics, Lederle Laboratories, Pearl River, New York, USA - 1988-89
Visiting Research Fellow at the Professorial Department of Rheumatology (Chair: Prof. Peter Brooks, M.D.), Royal North Shore Hospital, University of Sydney, Australia - 1990
Licensed Physician and M.D. (Dr. med.) thesis, advisor: Prof. Daniel Furst, theme: Analysis and meaning of the biliary elimination of methotrexate and its metabolites after giving “low dose” methotexate in chronic polyarthritis (Analyse und Bedeutung der biliären Elimination von Methotrexat und seiner Metaboliten nach Gabe von ”low dose” Methotrexat bei chronischer Polyarthritis) - 1989-2000
Research fellow and assistant (since 1995) at the Institute of Pharmacology (Chair: Prof. Günter Schultz, M.D.), Free University of Berlin - 1994
Medical Specialist in Pharmacology and Toxicology (Facharzt) - 1997
Habilitation in Pharmacology and Toxicology, mentor: Prof. Dr. Günter Schulz, theme: heterotrimeric G-proteins: new modifications, modulators and effectors (Heterotrimere G-Proteine: neue Modifikationen, Modulatoren und Effektoren) - 1998-1999
Calls to Associate-Professorships (C3) of Pharmacology and Toxicology at the Universities of Leipzig and Freiburg, rejected - 2000-2002
Associate Professor (C3) of Molecular Pharmacology, Department of Pharmacology and Toxicology (Chair: Prof. Peter Gierschik, M.D.), Medical Faculty, University of Ulm - 2002-2008
Full Professor of Biochemistry (C4) and Director of the Institute of Biochemistry and Molecularbiology II, University Hospital of the Heinrich-Heine-University Duesseldorf - 2005-2006
Vice Dean of the Medical Faculty, Heinrich-Heine-University Duesseldorf - 2006-2008
Dean of the Medical Faculty of the Heinrich-Heine-University and Member of the Executive Board of the University Hospitals and Clinics Duesseldorf - since 09/2008
Full Professor of Pharmacology and Toxicology (W3) and Director of the Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology at the University Hospital Tuebingen - since 2008
Member of the Executive Committee of the “Interfakultäres Zentrum für Pharmakogenomik und Arzneimittelforschung” (IZePhA, Interfaculty Centre of Pharmacogenomics and Drug Research)